BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Design Therapeutics Expands Board of Directors with Key Appointments

  Design Therapeutics, Inc. (Nasdaq: DSGN), today announced the appointments of industry veterans, Heather Behanna, Ph.D., principal of SR One, and Deepa Prasad, managing director of WestRiver Group, to its board of directors effective June 15, 2021.

  June 7, 2021

   · 

  6 min read
• Biotech Beach

  Histogen Announces $6.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

  Histogen Inc. (Nasdaq: HSTO), today announced that it has entered into definitive agreements with several institutional and accredited investors, for the purchase and sale of 5,977,300 shares of its common stock,

  June 7, 2021

   · 

  7 min read
• BioCapital

  Novavax to Participate in Panel at BIO Digital 2021

  Novavax, Inc. (Nasdaq: NVAX), today announced that Stanley C. Erck, President and Chief Executive Officer, will participate in a panel discussion at the BIO International Convention 2021 on June 14

  June 7, 2021

   · 

  4 min read
• Business

  Ironwood Pharmaceuticals Announces Leadership Updates

  Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), today announced that the Board of Directors named Thomas McCourt, who has served as president and interim chief executive officer since March 12, 2021, as permanent chief executive officer.

  June 7, 2021

   · 

  11 min read
• Genetown

  bluebird bio to Present at Goldman Sachs Global Healthcare Conference

  bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference.

  June 7, 2021

   · 

  1 min read
• Biotech Beach

  Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

  Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative genetic disorders, today reported that João Siffert, M.D., president and chief executive officer, will participate in a fireside chat during the Goldman Sachs 42nd Annual Global Healthcare Conference

  June 7, 2021

   · 

  1 min read
• Aurinia Announces Results of the 2021 Annual General Meeting

  Aurinia Pharmaceuticals Inc. is pleased to announce that the eight incumbent directors of the Company were elected at the Company’s annual general meeting held on June 7, 2021.

  June 7, 2021

   · 

  1 min read
• Biotech Beach

  UN Must Heed the Lessons of AIDS Pandemic to End COVID-19, says AHF

  After 40 years of fighting the AIDS pandemic, the overriding lesson of history is that the price of pharma greed and vaccine hoarding will be measured in human lives – unless world leaders act now.

  June 7, 2021

   · 

  2 min read
• Biotech Bay

  Innovative Analytical Software for Enhanced Data Acquisition and Analysis

  Scientists within academia and industries including pharmaceutical, biopharmaceutical and food and beverage analysis, can now benefit from new and improved software capabilities to enhance productivity and usability.

  June 7, 2021

   · 

  4 min read
• Pharm Country

  Harmony Biosciences To Present New Data Analyses For WAKIX® (pitolisant) At The SLEEP 2021 Annual Meeting

  Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), today announced that results from two post-hoc analyses from the clinical development program for WAKIX® (pitolisant) will be presented at the 35th Annual Meeting of the Associated Professional Sleep Societies

  June 7, 2021

   · 

  8 min read